Background illustration for clinical trials search

Paid Clinical Trials Arlington

Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

for
Relapsed/Refractory B-cell Malignancies
Location: Dallas TX, Denver CO, Columbus OH, Sarasota FL,
Sponsor: Accutar Biotechnology Inc

Sex: All

Age: 18+

Code: NCT05780034

Phase1, Recruiting

Quality of Pediatric Resuscitation in a Multicenter Collaborative

for
Cardiac Arrest, Cardiopulmonary Arrest
Location: Dallas TX, Austin TX, San Antonio TX, St Louis MO,
Sponsor: Children's Hospital of Philadelphia

Sex: All

Age: 0 - 18

Code: NCT02708134

Recruiting

Safety and Efficacy of Epcoritamab With Gemcitabine, Dexamethasone, and Cisplatin (GDP) Salvage Chemotherapy in Relapsed Refractory Large B-cell Lymphoma

for
Large Cell Lymphoma, Diffuse, Relapsed Cancer,
Location: Dallas TX, Indianapolis IN, Detroit MI,
Sponsor: Dipenkumar Modi

Sex: All

Age: 18+

Code: NCT05852717

Phase2, Recruiting

A Novel Multiplex ELISA Assay for Evaluating Patients With Microscopic Hematuria for Bladder Cancer

for
Bladder Cancer
Location: Dallas TX, Newport Beach CA, Long Beach CA,
Sponsor: Cedars-Sinai Medical Center

Sex: All

Age: 18 - 70+

Code: NCT03193541

Recruiting

Study of SGR-1505 in Mature B-Cell Neoplasms

for
Mature B-Cell Neoplasm, Non Hodgkin Lymphoma, DLBCL,
Location: Dallas TX, Gilbert AZ, Milwaukee WI, Columbus OH,
Sponsor: Schrödinger, Inc.

Sex: All

Age: 18+

Code: NCT05544019

Phase1, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

A Phase 1 Study of Anitocabtagene Autoleucel for the Treatment of Subjects With Non-oncology Plasma Cell-related Diseases

for
Muscular Diseases, Neuromuscular Manifestations, Autoimmune,
Location: Dallas TX, Houston TX, Rochester MN, Minneapolis MN,
Sponsor: Arcellx, Inc.

Sex: All

Age: 18+

Code: NCT06626919

Phase1, Recruiting

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

for
Pancreatic Ductal Adenocarcinoma,
Location: Dallas TX, Houston TX, Detroit MI, Miami FL,
Sponsor: PanTher Therapeutics

Sex: All

Age: 18+

Code: NCT06673017

Phase1, Recruiting

A Phase 1b/2a Study of Pocenbrodib as Monotherapy and in Combination With Darolutamide in Participants With mCRPC

for
mCRPC (Metastatic Castration-resistant Prostate Cancer),
Location: Dallas TX, Houston TX, Jefferson LA, St Louis MO,
Sponsor: Pathos AI, Inc.

Sex: Male

Age: 18+

Code: NCT06785636

Phase1, Phase2, Recruiting

Targeting Breathing Limitations to Improve Functional Outcomes in HFpEF

for
Heart Failure With Preserved Ejection Fraction, Obesity
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 55 - 70+

Code: NCT05723679

Recruiting

Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix

for
Cervical Cancer by FIGO Stage 2018
Location: Dallas TX, Little Rock AR, Burmingham AL, La Jolla CA,
Sponsor: Varian, a Siemens Healthineers Company

Sex: Female

Age: 18+

Code: NCT05197881

Recruiting

Acoramidis Transthyretin Amyloidosis Prevention Trial in the Young (ACT-EARLY) Study in Asymptomatic Carriers of a Pathogenic TTR Variant

for
Amyloidosis, Amyloid Cardiomyopathy, Transthyretin Amyloidosis,
Location: Dallas TX, Austin TX, Kansas City MO, St Louis MO,
Sponsor: Eidos Therapeutics, a BridgeBio company

Sex: All

Age: 18 - 70+

Code: NCT06563895

Phase3, Recruiting

A Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature

for
Idiopathic Short Stature
Location: Dallas TX, Houston TX, California City CA, Lafayette LA,
Sponsor: BioMarin Pharmaceutical

Sex: All

Age: 3 - 11

Code: NCT06382155

Phase2, Recruiting

A Post-Authorisation Safety Study (PASS) of Patients Treated With Lonapegsomatropin

for
Growth Hormone Deficiency
Location: Dallas TX, El Paso TX, Centennial CO, Iowa City IA,
Sponsor: Ascendis Pharma Endocrinology Division A/S

Sex: All

Age: 1 - 18

Code: NCT05775523

Recruiting

Cerebral Autoregulation, Brain Perfusion, and Neurocognitive Outcomes After Traumatic Brain Injury

for
Traumatic Brain Injury With Loss of Consciousness,
Location: Dallas TX
Sponsor: University of Texas Southwestern Medical Center

Sex: All

Age: 18 - 70+

Code: NCT06480838

Recruiting

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

for
Myelodysplastic Syndromes, Acute Myeloid Leukemia,
Location: Dallas TX, Houston TX, Nashville TN, Atlanta GA,
Sponsor: Taiho Oncology, Inc.

Sex: All

Age: 18+

Code: NCT04256317

Phase2, Phase3, Recruiting

Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib

for
Myelofibrosis, Post-PV MF, Post-ET Myelofibrosis,
Location: Dallas TX, Houston TX, San Antonio TX, Baton Rouge LA,
Sponsor: Kartos Therapeutics, Inc.

Sex: All

Age: 18+

Code: NCT06479135

Phase3, Recruiting

First-in-Human Study of Tersolisib (STX-478) as Monotherapy and in Combination With Other Antineoplastic Agents in Participants With Advanced Solid Tumors

for
Breast Cancer, Solid Tumors, Adult
Location: Dallas TX, Houston TX, San Antonio TX, Germantown TN,
Sponsor: Eli Lilly and Company

Sex: All

Age: 18+

Code: NCT05768139

Phase1, Phase2, Recruiting

Screening Emotions in Adolescents at the Hospital for mTBI

for
Brain Injury Traumatic Mild, Brain Injuries,
Location: Dallas TX, Houston TX, Milwaukee WI, Philadelphia PA,
Sponsor: University of California, Davis

Sex: All

Age: 11 - 17

Code: NCT06370520

Recruiting

A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Pallidotomy for the Treatment of Advanced, Idiopathic Parkinson's Disease With Medication-refractory Moderate to Severe Motor Complications

for
Movement Disorders, Neurology, Parkinsons Disease
Location: Dallas TX, Baltimore MD, Philadelphia PA, New York NY
Sponsor: InSightec

Sex: All

Age: 30 - 70+

Code: NCT05539196

Recruiting

Phase 3 Study to Evaluate the Efficacy and Safety of HER2/Neu Peptide GLSI-100 (GP2 + GM-CSF) in HER2/Neu Positive Subjects

for
Breast Cancer
Location: Dallas TX, Tyler TX, Austin TX, Houston TX,
Sponsor: Greenwich LifeSciences, Inc.

Sex: All

Age: 18 - 70+

Code: NCT05232916

Phase3, Recruiting